ACADIA Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. 

CEO
Catherine Owen Adams
CEOCatherine Owen Adams
Employees
798
Employees798
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1993
Founded1993
Employees
798
Employees798

ACAD Key Statistics

Market cap
3.38B
Market cap3.38B
Price-Earnings ratio
8.89
Price-Earnings ratio8.89
Dividend yield
—
Dividend yield—
Average volume
1.51M
Average volume1.51M
High today
$19.95
High today$19.95
Low today
$19.60
Low today$19.60
Open price
$19.72
Open price$19.72
Volume
226.24K
Volume226.24K
52 Week high
$30.96
52 Week high$30.96
52 Week low
$18.39
52 Week low$18.39

Stock Snapshot

The current ACADIA Pharmaceuticals(ACAD) stock price is $19.62, with a market capitalization of 3.38B. The stock trades at a price-to-earnings (P/E) ratio of 8.89.

On 2026-10-26, ACADIA Pharmaceuticals(ACAD) stock traded between a low of $19.60 and a high of $19.95. Shares are currently priced at $19.62, which is +0.1% above the low and -1.7% below the high.

ACADIA Pharmaceuticals(ACAD) shares are trading with a volume of 226.24K, against a daily average of 1.51M.

In the last year, ACADIA Pharmaceuticals(ACAD) shares hit a 52-week high of $30.96 and a 52-week low of $18.39.

In the last year, ACADIA Pharmaceuticals(ACAD) shares hit a 52-week high of $30.96 and a 52-week low of $18.39.

ACAD News

Simply Wall St 4h
Acadia Pharmaceuticals Stock Dropped, So What Is Driving Attention Now?

Advertisement Recent performance puts Acadia Pharmaceuticals in focus Acadia Pharmaceuticals (ACAD) has come under closer watch after a stretch of weaker shar...

Analyst ratings

71%

of 21 ratings
Buy
71.4%
Hold
23.8%
Sell
4.8%

People also own

Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.